ArticleInternational journal of pharmaceutics: X2026
EGFR-antibody-decorated cancer-cell-membrane-coated MOF nanoplatform enables targeted delivery of the STING agonist diABZI for pancreatic cancer immunotherapy.
Qingmin Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.